My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
The TARGET-D trial presented at AHA 2025 explores how targeted Vitamin D dosing can potentially lower the incidence of recurrent heart attacks among Acute Coronary Syndrome patients. While overall cardiovascular…
A sub-study from the VITAL trial found that daily supplementation of 2,000 IU of vitamin D3 significantly reduced leukocyte telomere shortening, translating to a nearly three-year delay in biological aging.…
This research review addresses nutritional strategies to prevent sarcopenia, an age-related muscle loss. It highlights the importance of specific nutrients, such as protein, vitamin D, leucine, creatine, and HMB, for…
The research from the DO-HEALTH trial investigates how vitamin D, omega-3 fatty acids, and exercise affect biological aging in 777 older adults. Findings reveal that combined lifestyle interventions significantly slow…
A recent study found that a butyrate-based supplement can benefit individuals with fatty liver disease and metabolic syndrome. Over a 3-month period, participants taking the supplement showed significant improvements in…
http://www.youtube.com/watch?v=-CjWEAiKY2Y Articles CoveredSupplements may protect those with low vitamin D levels from severe COVID-19https://www.eurekalert.org/pub_releases/2021-03/tes-smp031621.php#.YFZ7z2ZFpDg.wordpressCovid-19 risk increases with airborne pollenhttps://www.eurekalert.org/pub_releases/2021-03/tuom-cri030821.php#.YEf-KSTcvC8.wordpressFear of COVID-19 :https://www.eurekalert.org/pub_releases/2021-03/uov-foc031521.php#.YFAGH_X7fYo.wordpressVulnerable newborns being separated from their mothers in COVID-19…
You must be logged in to post a comment.